Results 191 to 200 of about 59,772 (269)
Prolonged Vancomycin‐Induced Linear IgA Disease in a Patient With Renal Failure
ABSTRACT A 64‐year‐old man with pneumococcal septic shock and subsequent renal failure underwent treatments with antibiotics including intravenous vancomycin (VCM). Blistering skin lesions appeared 10 days after the initiation of VCM. When the patient was transferred to us 5 months later, blisters with erythema were still observed on the abdomen and ...
Kaori Takezawa+5 more
wiley +1 more source
Sensitive Skin in Thais: Prevalence, Clinical Characteristics, and Diagnostic Cutoff Scores. [PDF]
Chaweekulrat P+5 more
europepmc +1 more source
Doxycycline, an antibiotic or an anti-inflammatory agent? The Most Common uses in dermatology
FJ Navarro‐Triviño+2 more
openalex +1 more source
Efficacy of Calcipotriol/Betamethasone Ointment in Facial Discoid Dermatosis
ABSTRACT Facial Discoid Dermatosis (FDD) is a rare chronic skin condition characterised by persistent, annular erythematous and desquamative papules on the face. Its aetiology is unclear, making differential diagnosis challenging. Key clinical features include pink‐orange, minimally scaling lesions limited to the face, sudden onset with long‐term ...
Alberto Murtas+4 more
wiley +1 more source
Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor [PDF]
Viswanath Reddy Belum+10 more
openalex +1 more source
ABSTRACT Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (1%–3% of CLE). There are two case reports to date in the literature of LEP potentially triggered by anti‐TNF‐α therapies. Clinically, it is characterised by tender, erythematous subcutaneous indurated nodules or plaques on fatty body areas.
Cristina Grechin+4 more
wiley +1 more source
ABSTRACT Background Biologic therapies have revolutionised psoriasis treatment by targeting immune pathways. Despite these advances, some patients experience suboptimal outcomes, necessitating frequent therapeutic switches. The systemic immune‐inflammation index (SII) is a novel biomarker for systemic inflammation.
Gregg Murray+7 more
wiley +1 more source
Optimizing Surgical Site Infection Prevention in Dermatologic Surgery. [PDF]
Sapijaszko M, Samadi S, Chow EY.
europepmc +1 more source
Risankizumab in Oncologic Patients With Psoriasis: A Case Series
JEADV Clinical Practice, EarlyView.
Michela Magnano+19 more
wiley +1 more source
Dermatomyositis-like Eruption Induced by Hydroxyurea-Case Report and Literature Review. [PDF]
Stoica LE+8 more
europepmc +1 more source